With a new $765,120 grant, Global Health professor Paul Drain will lead a study to develop an antigen-based COVID-19 test – as well as evaluate PCR-based tests and immunological assays – to be used at the point of care. This grant, sponsored by the Bill and Melinda Gates Foundation, is titled “Developing and Evaluating Point-of-Care Antigen and Immunoassays for COVID-19 and Cytokine Release Syndrome among people being screened for SARS-CoV-2 infection in Seattle”.

As part of 2020 Global Health Career Week, in collaboration with the School of Public Health, the Department of Global Health organized a week of Zoom sessions for participants to present information on their organization, their work, the culture of hiring, job or internship opportunities that might arise, and how students might best prepare for life after college.

By Mariel Boyarsky (MPH, 2015)

Mariel Boyarsky graduated from the University of Washington in 2015 with a Master of Public Health in Global Health. After completing nursing school, she began working at Kings County Hospital in Brooklyn, New York in 2019. This is Mariel's firsthand account of working in the hospital during the COVID-19 pandemic. 

Remdesivir, a non-specific antiviral drug that was originally tested against Ebola, has been shown to be effective against the new coronavirus in a preliminary data analysis, as reported by the National Institutes of Health. The UW School of Medicine was one of the sites in the National Institutes of Health trial. Dr.